Evidence map›Paper›PMID 38695528›Full record

ArticleJournal of clinical microbiology2024

Universal digital high-resolution melting for the detection of pulmonary mold infections.

Tyler Goshia, April Aralar, Nathan Wiederhold, Jeffrey D Jenks, Sanjay R Mehta, Aprajita Karmakar, Monish E S, Ankit Sharma, Haoxiang Sun, Refilwe Kebadireng and 4 more

Abstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Tyler GoshiaDepartment of Bioengineering, University of California San Diego, San Diego, California, USA.
April AralarDepartment of Bioengineering, University of California San Diego, San Diego, California, USA.
Nathan WiederholdDepartment of Pathology, University of Texas Health Science Center, San Antonio, Texas, USA.ORCID 0000-0002-2225-5122
Jeffrey D JenksDepartment of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Sanjay R MehtaDepartment of Medicine, University of California San Diego, San Diego, California, USA.
Aprajita KarmakarMelioLabs Inc., Santa Clara, California, USA.
Monish E SMelioLabs Inc., Santa Clara, California, USA.
Ankit SharmaMelioLabs Inc., Santa Clara, California, USA.
Haoxiang SunDepartment of Bioengineering, University of California San Diego, San Diego, California, USA.
Refilwe KebadirengDepartment of Bioengineering, University of California San Diego, San Diego, California, USA.
P Lewis WhitePublic Health Wales Microbiology Cardiff, Cardiff University, UHW, Cardiff, United Kingdom.ORCID 0000-0003-3056-4205
Mridu SinhaMelioLabs Inc., Santa Clara, California, USA.
Martin HoeniglDepartment of Internal Medicine, Medical University of Graz, Graz, Austria.ORCID 0000-0002-1653-2824
Stephanie I FraleyDepartment of Bioengineering, University of California San Diego, San Diego, California, USA.ORCID 0000-0003-1548-4442

Funding

Digital High Resolution Melt and Machine Learning for Rapid and Specific Diagnosis in Neonatal SepsisR01AI134982 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FRALEY, STEPHANIE IRENE · 2018 to 2022
$2.3M
A rapid test for congenital syphilis screeningR41HD107895 · NICHD · MELIOLABS INC. · PI FRALEY, STEPHANIE IRENE, SINHA, MRIDU · 2022 to 2022
$300k
Astellas Pharma US (APUS) ISR005824HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 1R41HD107895HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI134982NIAID NIH HHS R01 AI134982NICHD NIH HHS R41 HD107895
6 · The paper itself

Abstract

Invasive mold infections (IMIs) are associated with high morbidity, particularly in immunocompromised patients, with mortality rates between 40% and 80%. Early initiation of appropriate antifungal therapy can substantially improve outcomes, yet early diagnosis remains difficult to establish and often requires multidisciplinary teams evaluating clinical and radiological findings plus supportive mycological findings. Universal digital high-resolution melting (U-dHRM) analysis may enable rapid and robust diagnoses of IMI. A universal fungal assay was developed for U-dHRM and used to generate a database of melt curve signatures for 19 clinically relevant fungal pathogens. A machine learning algorithm (ML) was trained to automatically classify these pathogen curves and detect novel melt curves. Performance was assessed on 73 clinical bronchoalveolar lavage samples from patients suspected of IMI. Novel curves were identified by micropipetting U-dHRM reactions and Sanger sequencing amplicons. U-dHRM achieved 97% overall fungal organism identification accuracy and a turnaround time of ~4 hrs. U-dHRM detected pathogenic molds ( IMPORTANCE: Improvements in diagnostics for invasive mold infections are urgently needed. This work presents a new molecular detection approach that addresses technical and workflow challenges to provide fast pathogen detection, identification, and quantification that could inform treatment to improve patient outcomes.

Indexed as

FungiLung Diseases, FungalSensitivity and SpecificityBronchoalveolar Lavage FluidHumansInvasive Fungal InfectionsMachine LearningMolecular Diagnostic TechniquesTransition TemperaturedPCRHRMIMImachine learning

Identifiers

PMID38695528
PMCPMC11237519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.